Epilepsy Trial, Recruiting (NCT04653012)

Epilepsy Trial, Recruiting NCT04653012 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT04653012 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have epilepsy that has not been controlled by medication, and the seizures come from a specific area of the brain
You are already scheduled to have electrodes placed inside your skull to help doctors find where your seizures are coming from, as part of pre-surgery testing at the Pitié-Salpêtrière hospital in the Neurology department
You have been fully informed about the study and have agreed to take part by signing a consent form

Who may not be able to join:

You have a condition that makes it unsafe to have electrodes placed inside your skull, such as a current infection, or a serious heart, lung, kidney, or liver problem, or a weakened immune system (for example, if you are taking medication that suppresses your immune system)
You are currently pregnant or in labour
You are currently breastfeeding
You are under 18 years old, or you are an adult who has a legal guardian or is under court-ordered protection (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01 42 16 19 40

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04653012

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 01 42 16 19 40

More information: https://clinicaltrials.gov/study/NCT04653012

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have epilepsy that has not been controlled by medication, and the seizures come from a specific area of the brain
You are already scheduled to have electrodes placed inside your skull to help doctors find where your seizures are coming from, as part of pre-surgery testing at the Pitié-Salpêtrière hospital in the Neurology department
You have been fully informed about the study and have agreed to take part by signing a consent form

Who may not be able to join:

You have a condition that makes it unsafe to have electrodes placed inside your skull, such as a current infection, or a serious heart, lung, kidney, or liver problem, or a weakened immune system (for example, if you are taking medication that suppresses your immune system)
You are currently pregnant or in labour
You are currently breastfeeding
You are under 18 years old, or you are an adult who has a legal guardian or is under court-ordered protection (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Registry

ClinicalTrials.gov

Start date

28 February 2021

Est. completion

27 February 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Identification of single unit changes at seizure emergence; Identification of local field potential (LFP) changes at seizure emergence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov